Armata Pharmaceuticals In...

AMEX: ARMP · Real-Time Price · USD
2.55
0.02 (0.79%)
At close: Aug 15, 2025, 3:56 PM
2.34
-8.24%
After-hours: Aug 15, 2025, 06:13 PM EDT

Armata Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
2.17M 491K 1.24M 2.97M n/a 966K 1.53M 1.23M 980K 796K 1.05M 1.34M 1.88M 1.24M n/a n/a n/a 1.07M
Cost of Revenue
366K 377K 380K 313K 315K 317K 293K 33.05M 200K 230K 245K 226K 195K 8.03M 4.81M 5.63M 5.22M 4.35M
Gross Profit
1.8M 114K 855K 2.66M -315K 649K 1.24M 1M 780K 566K 806K 1.11M 1.69M n/a n/a n/a n/a -3.28M
Operating Income
-6.84M -8.19M -10.54M -9.76M -11.91M -10.23M -9.58M -10.34M -9.63M -11.35M -10.33M -8.62M -9.22M -8.78M -6.05M -6.14M -6.2M -5.43M
Interest Income
108K 59K 130K 294K 221K 52K 68K 47K 46K 18K 14K 9K 5K 1K 1K n/a 2K 2K
Pretax Income
-16.3M -6.53M 2.6M -5.48M 8.99M -25.02M -19.85M -31.16M -3.55M -14.49M -10.31M -8.61M -9.21M -8.77M -6.05M -5.42M -6.19M -5.5M
Net Income
-16.3M -6.53M 2.6M -5.48M 8.99M -25.02M -19.85M -31.16M -3.55M -14.49M -10.3M -8.61M -9.21M -8.77M -6.05M -5.42M -6.19M -5.5M
Selling & General & Admin
2.62M 3.25M 3.32M 3.24M 3.44M 3.18M 3.18M 3.58M 2.35M 2.54M 1.81M 1.56M 2.08M 1.98M 2.22M 1.77M 2.14M 2.15M
Research & Development
6.39M 5.43M 8.45M 9.48M 8.47M 8.02M 7.93M 7.98M 8.26M 9.6M 9.57M 8.4M 9.02M 8.03M 4.81M 5.63M 5.22M 4.35M
Other Expenses
-366K -377K -379K -323K -315K -317K -293K -221K -980K -796K -1.05M -1.34M -1.88M -1.24M -989K -1.25M -1.17M -1.07M
Operating Expenses
8.65M 8.3M 11.39M 12.41M 11.6M 10.88M 10.81M 11.34M 9.63M 11.35M 10.33M 8.62M 9.22M 1.98M 6.05M 6.14M 6.2M 2.15M
Interest Expense
3.81M 3.6M 3.28M 2.92M 2.72M 1.82M 1.45M 1.18M n/a n/a n/a n/a n/a n/a n/a 2K n/a 62K
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
9.01M 8.68M 11.77M 12.73M 11.91M 11.19M 11.11M 11.56M 9.63M 11.35M 10.33M 8.62M 9.22M 10.01M 6.05M 6.14M 6.2M 5.43M
Income Tax Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -14K -9K -5K -1K 1K 2K 2K n/a
Shares Outstanding (Basic)
36.19M 36.19M 36.18M 36.18M 36.16M 36.13M 36.1M 36.09M 36.07M 36.05M 36.05M 36.04M 35.44M 29M 24.1M 24.82M 24.76M 20.46M
Shares Outstanding (Diluted)
36.19M 36.19M 59.08M 36.18M 58.25M 36.13M 36.1M 36.09M 36.07M 36.05M 36.05M 36.04M 36M 29M 24.1M 24.82M 24.76M 20.46M
EPS (Basic)
-0.45 -0.18 0.07 -0.15 0.25 -0.69 -0.55 -0.86 -0.1 -0.4 -0.29 -0.24 -0.26 -0.3 -0.25 -0.22 -0.25 -0.27
EPS (Diluted)
-0.45 -0.18 0.04 -0.15 -0.25 -0.69 -0.55 -0.86 -0.1 -0.4 -0.29 -0.24 -0.26 -0.3 -0.25 -0.22 -0.25 -0.27
EBITDA
-12.12M -2.55M 6.26M -2.25M 12.02M -22.88M -18.1M -29.76M -3.32M -14.26M -10.07M -8.39M -9.03M -8.55M -5.77M -5.1M -5.9M -5.15M
EBIT
-12.49M -2.93M 5.88M -2.56M 11.7M -23.2M -18.4M -29.98M -3.55M -14.49M -10.31M -8.61M -9.22M -8.78M -6.05M -5.42M -6.19M -5.43M
Depreciation & Amortization
366K 377K 380K 313K 315K 317K 293K 221K 200K 230K 245K 226K 200K 227K 277K 300K 297K 281K